Bruker (BRKR) Stock Forecast & Price Target

Bruker Corporation is positioned for a positive outlook, driven by an anticipated increase in adjusted gross margins, which improved by 10 basis points to 51.3%. The company expects a recovery in fiscal year 2026, with management indicating that tariff and administrative impacts will be resolved, allowing for growth in adjusted earnings. Despite the revised guidance for adjusted EPS being lower than previous expectations, the emphasis on margin improvement and recovery signals a potentially favorable financial trajectory.

Bruker Corporation's outlook has been negatively impacted by a revised operating margin expectation of flat for FY25, a significant decline from a previously projected increase of 140 basis points. Management anticipates softer market conditions in both the US and China, resulting in a low-single-digit organic revenue decline and a downward adjustment in the organic growth forecast to a range of 0% to 2%, below market expectations. Although total revenue growth estimates have slightly increased, driven by M&A and favorable foreign exchange impacts, overall revenue projections remain modest, positioning them at the lower end of analyst estimates.